Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
1,25-dihydroxyvitamin D in chronic kidney disease
IRCT201211106415N3Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of calcitriol in chronic kidney disease (CKD), sponsored by Tehran University of Medical Sciences. Primary endpoints: Change in carotid intima-media thickness (IMT), Change in iron indicators affected by inflammation and 1 more. Started Apr 2013; status: completed.
02
Drugs
calcitriol
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on IRCT201211106415N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201211106415N3.